---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-045057"
form_type: "8-K"
ticker: null
cik: "0001106838"
company_name: "Sonnet BioTherapeutics Holdings, Inc."
filed_at: "2023-12-15T23:59:59+00:00"
generated_at: "2026-06-07T11:41:07.492904+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Sonnet BioTherapeutics gets Nasdaq delisting notice; stockholders' equity negative $226K

## Summary
- Nasdaq notified Sonnet on Dec 15, 2023 of non-compliance with $2.5M minimum stockholders' equity requirement.
- Stockholders' equity reported at ($225,980) as of Sept 30, 2023, below the continued listing standard.
- Company has 45 calendar days (by Jan 29, 2024) to submit a plan to regain compliance to Nasdaq.
- If plan accepted, Nasdaq may grant up to 180 days from notice date to evidence compliance.
- Failure to regain compliance could result in delisting from Nasdaq Capital Market, harming liquidity and capital access.

## SEC filing metadata
- accession: 0001493152-23-045057
- form_type: 8-K
- cik: 0001106838
- company_name: Sonnet BioTherapeutics Holdings, Inc.
- filed_at: 2023-12-15T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1106838/000149315223045057/0001493152-23-045057-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1106838/000149315223045057/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-045057
- JSON: https://secwatch.observer/filing/0001493152-23-045057.json
- Plain text: https://secwatch.observer/filing/0001493152-23-045057.txt

## Key facts
- Listing & Compliance Notices
  Sonnet BioTherapeutics Holdings, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: “Stockholders’ Equity Requirement”). In the Company’s Annual Report on Form 10-K for the year ended September 30, 2023, the Company reported stockholders’ equity (deficit) of $(225,980), which is below the Stockholders’ Equity Requirement for continued listing. Additionally, as of the date of this report, the Company does not meet either of the alternative
  evidence_url: https://www.sec.gov/Archives/edgar/data/1106838/000149315223045057/0001493152-23-045057-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.